Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample.
Introduction and Objectives: ACLF is a syndrome characterized by multiorgan failure due to acute decompensation in chronic liver disease, with high short-term mortality. Therefore, scales have been designed to predict prognosis and early mortality. Evaluation of MELD, MELD NA, MELD LACTATE, and MELD...
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Elsevier
2024-02-01
|
| Σειρά: | Annals of Hepatology |
| Διαθέσιμο Online: | http://www.sciencedirect.com/science/article/pii/S1665268124002321 |
| _version_ | 1827325496693620736 |
|---|---|
| author | Sandra Teutli-Carrión Claudia L Dorantes-Nava José L. Pérez-Hernández |
| author_facet | Sandra Teutli-Carrión Claudia L Dorantes-Nava José L. Pérez-Hernández |
| author_sort | Sandra Teutli-Carrión |
| collection | DOAJ |
| description | Introduction and Objectives: ACLF is a syndrome characterized by multiorgan failure due to acute decompensation in chronic liver disease, with high short-term mortality. Therefore, scales have been designed to predict prognosis and early mortality. Evaluation of MELD, MELD NA, MELD LACTATE, and MELD 3.0 scales for survival prediction in ACLF patients Materials and Patients: Observational, retrospective, and analytical study, scales were calculated, and sensitivity (S) and specificity (E) were determined using CLIF-C-ACLF as reference through ROC curves. Cut-off points were established at the maximum values of S and E. Cumulative mortality percentage by Kaplan-Meier, and comparison of ACLF grades with the Long-Rank test with p<0.005. Results: 233 patients were included, 165 (71%) males, with a mean age of 52 years ± 12.96. The etiology was alcohol-related in 158 (68%) cases. ACLF grade distribution, it was 1: 37%, 2: 41%, and 3: 22%. The MELD 3.0 showed the highest discriminatory power for ACLF grade 3, with AUC of 0.91 (95% CI:0.86-0.96), a cut-off point of 34.5, sensitivity of 86%, and specificity of 80% (Figures 1). The 2-year mortality rate was 123 (52%); 30 (35%), 51 (53%), and 42 (82%) for grades 1, 2, and 3, respectively, with a significant Log-Rank test, chi-square = 34.99, p <0.001. The mean survival by grades was 17 months for grade 1, 13 months for grade 2, and 5 months for grade 3 (Figure 2) Conclusions: The MELD 3.0 scale showed better performance as a tool to evaluate severity and predict short-term mortality risk in ACLF patients. |
| first_indexed | 2024-03-07T14:30:06Z |
| format | Article |
| id | doaj.art-71068726c6df492fa7f4636c84897e8a |
| institution | Directory Open Access Journal |
| issn | 1665-2681 |
| language | English |
| last_indexed | 2024-03-07T14:30:06Z |
| publishDate | 2024-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj.art-71068726c6df492fa7f4636c84897e8a2024-03-06T05:26:09ZengElsevierAnnals of Hepatology1665-26812024-02-0129101438Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample.Sandra Teutli-Carrión0Claudia L Dorantes-Nava1José L. Pérez-Hernández2Department of Gastroenterology and Hepatology, Hospital General de Mexico ''Dr. Eduardo LiceagaDepartment of Gastroenterology and Hepatology, Hospital General de Mexico ''Dr. Eduardo LiceagaDepartment of Gastroenterology and Hepatology, Hospital General de Mexico ''Dr. Eduardo LiceagaIntroduction and Objectives: ACLF is a syndrome characterized by multiorgan failure due to acute decompensation in chronic liver disease, with high short-term mortality. Therefore, scales have been designed to predict prognosis and early mortality. Evaluation of MELD, MELD NA, MELD LACTATE, and MELD 3.0 scales for survival prediction in ACLF patients Materials and Patients: Observational, retrospective, and analytical study, scales were calculated, and sensitivity (S) and specificity (E) were determined using CLIF-C-ACLF as reference through ROC curves. Cut-off points were established at the maximum values of S and E. Cumulative mortality percentage by Kaplan-Meier, and comparison of ACLF grades with the Long-Rank test with p<0.005. Results: 233 patients were included, 165 (71%) males, with a mean age of 52 years ± 12.96. The etiology was alcohol-related in 158 (68%) cases. ACLF grade distribution, it was 1: 37%, 2: 41%, and 3: 22%. The MELD 3.0 showed the highest discriminatory power for ACLF grade 3, with AUC of 0.91 (95% CI:0.86-0.96), a cut-off point of 34.5, sensitivity of 86%, and specificity of 80% (Figures 1). The 2-year mortality rate was 123 (52%); 30 (35%), 51 (53%), and 42 (82%) for grades 1, 2, and 3, respectively, with a significant Log-Rank test, chi-square = 34.99, p <0.001. The mean survival by grades was 17 months for grade 1, 13 months for grade 2, and 5 months for grade 3 (Figure 2) Conclusions: The MELD 3.0 scale showed better performance as a tool to evaluate severity and predict short-term mortality risk in ACLF patients.http://www.sciencedirect.com/science/article/pii/S1665268124002321 |
| spellingShingle | Sandra Teutli-Carrión Claudia L Dorantes-Nava José L. Pérez-Hernández Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. Annals of Hepatology |
| title | Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. |
| title_full | Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. |
| title_fullStr | Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. |
| title_full_unstemmed | Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. |
| title_short | Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample. |
| title_sort | evaluation of severity and survival scales in acute on chronic liver failure aclf in a mexican population sample |
| url | http://www.sciencedirect.com/science/article/pii/S1665268124002321 |
| work_keys_str_mv | AT sandrateutlicarrion evaluationofseverityandsurvivalscalesinacuteonchronicliverfailureaclfinamexicanpopulationsample AT claudialdorantesnava evaluationofseverityandsurvivalscalesinacuteonchronicliverfailureaclfinamexicanpopulationsample AT joselperezhernandez evaluationofseverityandsurvivalscalesinacuteonchronicliverfailureaclfinamexicanpopulationsample |